Sakuma R - Search Results

1

Robust Enhancement of Lentivirus Production by Promoter Activation.

Suzuki N, Yoshida T, Takeuchi H, Sakuma R, Sukegawa S, Yamaoka S. Suzuki N, et al. Among authors: sakuma r. Sci Rep. 2018 Oct 11;8(1):15036. doi: 10.1038/s41598-018-33042-5. Sci Rep. 2018. PMID: 30310119 Free PMC article.

2

Suppressor of cytokine signaling 1 counteracts rhesus macaque TRIM5α-induced inhibition of human immunodeficiency virus type-1 production.

Sukegawa S, Sakuma R, Ohmine S, Takeuchi H, Ikeda Y, Yamaoka S. Sukegawa S, et al. Among authors: sakuma r. PLoS One. 2014 Oct 13;9(10):e109640. doi: 10.1371/journal.pone.0109640. eCollection 2014. PLoS One. 2014. PMID: 25310711 Free PMC article.

3

SIV replication in human cells.

Sakuma R, Takeuchi H. Sakuma R, et al. Front Microbiol. 2012 Apr 27;3:162. doi: 10.3389/fmicb.2012.00162. eCollection 2012. Front Microbiol. 2012. PMID: 22679440 Free PMC article.

4

A carboxy-terminally truncated human CPSF6 lacking residues encoded by exon 6 inhibits HIV-1 cDNA synthesis and promotes capsid disassembly.

Hori T, Takeuchi H, Saito H, Sakuma R, Inagaki Y, Yamaoka S. Hori T, et al. Among authors: sakuma r. J Virol. 2013 Jul;87(13):7726-36. doi: 10.1128/JVI.00124-13. Epub 2013 May 8. J Virol. 2013. PMID: 23658440 Free PMC article.

5

The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.

Ohmine S, Sakuma R, Sakuma T, Thatava T, Takeuchi H, Ikeda Y. Ohmine S, et al. Among authors: sakuma r, sakuma t. PLoS One. 2011 Jan 14;6(1):e16121. doi: 10.1371/journal.pone.0016121. PLoS One. 2011. PMID: 21264255 Free PMC article.

6

Inhibitory and enhancing effects of insertion of central polypurine tract sequence on gene expression with vectors derived from human immunodeficiency virus type 1.

Sakuma R, Kobayashi N, Ae K, Kitamura Y. Sakuma R, et al. Biochem Biophys Res Commun. 2003 Mar 14;302(3):489-95. doi: 10.1016/s0006-291x(03)00212-2. Biochem Biophys Res Commun. 2003. PMID: 12615060

7

Packageable antiviral therapeutics against human immunodeficiency virus type 1: virion-targeted virus inactivation by incorporation of a single-chain antibody against viral integrase into progeny virions.

Okui N, Sakuma R, Kobayashi N, Yoshikura H, Kitamura T, Chiba J, Kitamura Y. Okui N, et al. Among authors: sakuma r. Hum Gene Ther. 2000 Mar 1;11(4):537-46. doi: 10.1089/10430340050015725. Hum Gene Ther. 2000. PMID: 10724032

8

Virion-targeted viral inactivation: new therapy against viral infection.

Okui N, Kitamura Y, Kobayashi N, Sakuma R, Ishikawa T, Kitamura T. Okui N, et al. Among authors: sakuma r. Mol Urol. 2001 Summer;5(2):59-66. doi: 10.1089/109153601300177565. Mol Urol. 2001. PMID: 11690549

9

Integrase of human endogenous retrovirus K-10 supports the replication of replication-incompetent Int- human immunodeficiency virus type 1 mutant.

Ogata T, Okui N, Sakuma R, Kobayashi N, Kitamura Y. Ogata T, et al. Among authors: sakuma r. Jpn J Infect Dis. 1999 Dec;52(6):251-2. Jpn J Infect Dis. 1999. PMID: 10738367 No abstract available.

10

Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins.

Sakuma R, Noser JA, Ohmine S, Ikeda Y. Sakuma R, et al. Nat Med. 2007 May;13(5):631-5. doi: 10.1038/nm1562. Epub 2007 Apr 15. Nat Med. 2007. PMID: 17435772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters